Feature Channels: Alzheimer's and Dementia

Filters close
7-Oct-2022 5:05 PM EDT
Are More Hot Flashes, Night Sweats During Menopause Linked to Worse Brain Health?
American Academy of Neurology (AAN)

Women who experience more hot flashes and night sweats during menopause may have more of a brain biomarker called white matter hyperintensities, according to a new study published in the October 12, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

7-Oct-2022 5:05 PM EDT
Does the Mediterranean Diet Really Decrease Your Risk of Dementia?
American Academy of Neurology (AAN)

A number of studies have suggested that eating a healthy diet may reduce a person’s risk of dementia, but a new study has found that two diets including the Mediterranean diet are not linked to a reduced risk of dementia. The study is published in the October 12, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: New Guidance Published on Addressing Underrepresentation in Genomics
Released: 11-Oct-2022 5:05 PM EDT
New Guidance Published on Addressing Underrepresentation in Genomics
University of Miami Health System, Miller School of Medicine

Researchers at the University of Miami Miller School of Medicine collaborated on a recently published paper that provides new guidance on inclusion of underrepresented populations in genetics research.

Newswise: Blood Levels of ‘Free Range’ DNA May Signal Early Detection of Dementia and Frailty
Released: 11-Oct-2022 10:00 AM EDT
Blood Levels of ‘Free Range’ DNA May Signal Early Detection of Dementia and Frailty
Johns Hopkins Medicine

In a long-term prospective study of more than 600 older participants, Johns Hopkins Medicine researchers say they have evidence that higher levels of cell-free DNA circulating in the blood may signal increased risk of chronic inflammation associated with early signs of frailty and dementia.

Released: 7-Oct-2022 5:25 PM EDT
Detecting Alzheimer’s disease in the blood
Hokkaido University

Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples.

Released: 7-Oct-2022 1:05 PM EDT
ACS awarded grant to develop resources for older adults with cognitive impairments undergoing surgery
American College of Surgeons (ACS)

The American College of Surgeons (ACS) is the recipient of a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to develop comprehensive educational resources to improve surgical care and outcomes for older adults with Alzheimer’s disease and related dementias who are undergoing surgery.

5-Oct-2022 12:15 PM EDT
Schizophrenia may increase dementia risk by 2.5 times
University College London

People with psychotic disorders such as schizophrenia are 2.5 times more likely than those without a psychotic disorder to eventually develop dementia, according to a review of evidence led by UCL researchers.

Released: 4-Oct-2022 3:20 PM EDT
Indiana University Researchers Receive $3.96 Million to Test Dementia Care App
Indiana University

The National Institutes of Health's National Institute on Aging (NIA) recently awarded researchers from Indiana University's School of Public Health-Bloomington and School of Medicine $3.96 million to fund a five-year, randomized clinical trial of an Alzheimer’s disease and related dementia (ADRD) telehealth intervention.

   
Newswise: Why women may be more susceptible to Alzheimer’s disease
Released: 4-Oct-2022 11:50 AM EDT
Why women may be more susceptible to Alzheimer’s disease
Case Western Reserve University

Case Western Reserve University researchers have identified a mechanism in brain tissue that may explain why women are more vulnerable to Alzheimer’s disease—a finding that they say could help lead to new medicines to treat the disease. The researchers found that the female brain shows higher expression of a certain enzyme compared to males, resulting in greater accumulation of a protein called tau.

Newswise: Alzheimer's and Dementia: The Journal of the Alzheimer's Association announces UK's Donna Wilcock as new editor-in-chief
Released: 3-Oct-2022 4:10 PM EDT
Alzheimer's and Dementia: The Journal of the Alzheimer's Association announces UK's Donna Wilcock as new editor-in-chief
University of Kentucky

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.Since its inception in 2005, Alzheimer’s & Dementia has sought to bridge the knowledge gaps that separate traditional fields of dementia research by rapidly disseminating new findings and acting as a forum for articles covering clinical investigations and basic, social and behavioral research.

Released: 3-Oct-2022 4:05 PM EDT
Suicide risk almost seven times higher after diagnosis of young onset dementia
Queen Mary University of London

In the UK, around 850,000 people are currently living with dementia and it’s the leading cause of death.

Released: 30-Sep-2022 4:30 PM EDT
Improving hospital stays and outcomes for older patients with dementia through AI
Houston Methodist

By using artificial intelligence, Houston Methodist researchers are able to predict hospitalization outcomes of geriatric patients with dementia on the first or second day of hospital admission. This early assessment of outcomes means more timely interventions, better care coordination, more judicious resource allocation, focused care management and timely treatment for these more vulnerable, high-risk patients. The study is available online in Alzheimer’s & Dementia: Translational Research and Clinical Interventions, a journal of the Alzheimer’s Association.

Newswise: New Study Shows People with Glaucoma are at Significant Risk of Alzheimer’s Disease
Released: 30-Sep-2022 10:05 AM EDT
New Study Shows People with Glaucoma are at Significant Risk of Alzheimer’s Disease
American Academy of Ophthalmology (AAO)

A large, nationwide study from Taiwan shows that people with normal-tension glaucoma are at high risk for developing Alzheimer’s disease.

Released: 30-Sep-2022 8:05 AM EDT
Race and Ethnicity Influence End-of-Life Care for Medicare Patients With Dementia
Rutgers University-New Brunswick

Mechanical ventilation, intubation and other intensive treatments are prescribed more often to racial and ethnic minorities, a Rutgers study finds

Released: 29-Sep-2022 1:10 PM EDT
Breaks in ‘junk’ DNA give scientists new insight into neurological disorders
University of Sheffield

New study identifies how oxidative breaks form and are repaired in what scientists thought to be ‘junk’ DNA

Newswise: National Institutes of Health Awards Cleveland Clinic $10.7 Million to Expand National Consortium Studying Dementia with Lewy Bodies
Released: 29-Sep-2022 10:50 AM EDT
National Institutes of Health Awards Cleveland Clinic $10.7 Million to Expand National Consortium Studying Dementia with Lewy Bodies
Cleveland Clinic

The National Institutes of Health (NIH) awarded a $10.7 million five-year renewal grant to Cleveland Clinic to expand a national research consortium focused on improving the diagnosis and treatments for Dementia with Lewy Bodies. The Dementia with Lewy Bodies Consortium, established in 2017, centralized research efforts and created a national, coordinated registry for clinical data.

Newswise: Metabolism linked to brain health say UniSA researchers
Released: 29-Sep-2022 4:05 AM EDT
Metabolism linked to brain health say UniSA researchers
University of South Australia

A world-first study from the University of South Australia’s Australian Centre for Precision Health has found a link between metabolism and dementia-related brain measures, providing valuable insights about the disease.

Released: 28-Sep-2022 12:15 PM EDT
High blood pressure speeds up mental decline, but does not fully explain dementia disparities
Michigan Medicine - University of Michigan

High blood pressure means faster slide into signs of dementia or Alzheimer’s, but does not explain the overall disparity between Hispanic/Latino people and non-Hispanic people in dementia risk.

Released: 27-Sep-2022 2:10 PM EDT
The latest research and expert commentary on guns and violence
Newswise

Here are some of the latest articles that have been posted in the Guns and Violence channel on Newswise.

       
Released: 27-Sep-2022 10:25 AM EDT
Study finds different comorbidities have different impacts on COVID outcomes
Oxford University Press

A new paper in Biology Methods & Protocols, published by Oxford University Press, indicates that some pre-existing conditions—including degenerative neurological diseases, dementia, and severe disabilities—matter a lot more than once thought when assessing who is at risk for death due to COVID-19.

Newswise: Alzheimer’s Association Awards Grant to Wake Forest University School of Medicine for Alzheimer’s Research
Released: 26-Sep-2022 8:05 AM EDT
Alzheimer’s Association Awards Grant to Wake Forest University School of Medicine for Alzheimer’s Research
Wake Forest University School of Medicine

The Alzheimer's Association, through its Part the Cloud global research grant program, has awarded Wake Forest University School of Medicine $795,000 over two years to study potential treatments for Alzheimer's disease.

Released: 22-Sep-2022 2:50 PM EDT
Landmark Study of Biomarker Data May Enable Better Treatment for Early Onset Dementia
University of California, San Francisco (UCSF)

In a study publishing in Nature Medicine on September 22, 2022, University of California San Francisco researchers Adam Staffaroni, PhD, and Adam Boxer, MD, PhD, combined and harmonized clinical, neuroimaging, and fluid biomarkers from nearly all familial FTD clinical research participants across North America and Europe. With that data, they developed models of clinical and biomarker dynamics to determine the temporal sequence of biomarker and clinical changes in f-FTD before disease progression begins.

Released: 21-Sep-2022 5:00 PM EDT
UCI Alzheimer’s project wins $47 million grant from National Institute on Aging
University of California, Irvine

Irvine, Calif., Sept. 20, 2022 — What began with a $70,000 philanthropic gift 12 years ago has grown into the recipient of a $47 million National Institute on Aging grant for Alzheimer’s disease research at the University of California, Irvine. The funds will be parceled out over five years to a UCI team developing the next generation of mouse models for studying late-onset Alzheimer’s.

Released: 21-Sep-2022 1:45 PM EDT
Nightmares in middle age linked to dementia risk
University of Birmingham

People who experience frequent bad dreams in middle age are more likely to be diagnosed with dementia later in life, according to research at the University of Birmingham.

Released: 20-Sep-2022 1:45 PM EDT
National Prion Disease Pathology Surveillance Center to receive up to $20 million in CDC grant funding for continued research into fatal neurodegenerative prion diseases in brain
Case Western Reserve University

The National Prion Disease Pathology Surveillance Center (NPDPSC) at Case Western Reserve University will receive up to $20 million in funding as part of a grant renewal from the Centers for Disease Control and Prevention (CDC) to better understand how and why prion diseases––degenerative brain conditions found in both humans and animals—develop and spread.

Newswise: Researchers test hybrid, soft/hard nanocarriers to deliver drugs to the brain
Released: 20-Sep-2022 11:25 AM EDT
Researchers test hybrid, soft/hard nanocarriers to deliver drugs to the brain
Iowa State University

Researchers are working to develop nanocarriers that deliver drugs across the blood brain barrier. Successful nanocarriers could lead to treatments for brain disorders including Alzheimer's disease, Parkinson’s disease, ischemic stroke, epilepsy and seizures.

   
Released: 20-Sep-2022 6:05 AM EDT
As health problems stack up, so do serious financial woes, study shows
Michigan Medicine - University of Michigan

Being in “poor health” is far more than just a saying, according to a new University of Michigan study. In fact, adults’ risk of serious financial problems rises directly with the number of chronic health conditions they have, the study of medical and financial data from nearly 3 million privately insured adults finds.

Released: 16-Sep-2022 2:25 PM EDT
Cognitive health may benefit from balanced meal timing
Higher Education Press

Globally, there are approximately 55 million people who suffer from dementia, and the incidence of the disease has steadily increased.

Newswise: Adults Show Poorer Cognition, Better Well-Being with Age
Released: 15-Sep-2022 10:40 AM EDT
Adults Show Poorer Cognition, Better Well-Being with Age
University of California San Diego

A UC San Diego study identifies neural mechanisms contributing to poorer cognition in aging adults; results may inspire new clinical interventions

12-Sep-2022 10:05 AM EDT
Seven Healthy Lifestyle Habits May Reduce Dementia Risk for People with Diabetes
American Academy of Neurology (AAN)

A combination of seven healthy lifestyle habits including sleeping seven to nine hours daily, exercising regularly and having frequent social contact was associated with a lower risk of dementia in people with type 2 diabetes, according to a study published in the September 14, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: AI: Cedars-Sinai Awarded $8M to Study Alzheimer’s Disease
Released: 14-Sep-2022 12:10 PM EDT
AI: Cedars-Sinai Awarded $8M to Study Alzheimer’s Disease
Cedars-Sinai

The Cedars-Sinai Department of Computational Biomedicine has received an $8 million grant from the National Institutes of Health to study Alzheimer’s disease.

Newswise: Daily Multivitamin May Improve Cognition and Possibly Protect Against Decline
12-Sep-2022 12:05 PM EDT
Daily Multivitamin May Improve Cognition and Possibly Protect Against Decline
Wake Forest University School of Medicine

New research from Wake Forest University School of Medicine shows that taking a daily supplement may improve cognition in older adults. In the study, researchers estimated that three years of multivitamin supplementation roughly translated to a 60% slowing of cognitive decline (about 1.8 years).

Newswise: Risk Factor for Developing Alzheimer’s Disease Increases by 50-80% in Older Adults Who Caught COVID-19
Released: 13-Sep-2022 12:20 PM EDT
Risk Factor for Developing Alzheimer’s Disease Increases by 50-80% in Older Adults Who Caught COVID-19
Case Western Reserve University

Older people who were infected with COVID-19 show a substantially higher risk—as much as 50% to 80% higher than a control group—of developing Alzheimer’s disease within a year, according to a study of more than 6 million patients 65 and older.

Released: 13-Sep-2022 11:05 AM EDT
La preeclampsia se relaciona con indicadores de alto riesgo para daño e inflamación en células cerebrales
Mayo Clinic

Según los investigadores de Mayo Clinic, las mujeres con antecedentes de preeclampsia grave tienen más indicadores de un mayor riesgo de sufrir daño e inflamación en las células del cerebro en comparación con aquellas que tuvieron embarazos sin complicaciones.

Released: 13-Sep-2022 11:05 AM EDT
A Pré-eclâmpsia está associada a indicadores de maior risco de danos e inflamação nas células cerebrais
Mayo Clinic

Pesquisadores da Mayo Clinic descobriram que mulheres com histórico de pré-eclâmpsia grave têm mais indicadores de maior risco de danos e inflamação das células cerebrais em comparação com mulheres que tiveram gestações sem complicações.

Newswise: How Memory of Personal Interactions Declines with Age
Released: 8-Sep-2022 11:30 AM EDT
How Memory of Personal Interactions Declines with Age
University of Maryland School of Medicine

One of the most upsetting aspects of age-related memory decline is not being able to remember the face that accompanies the name of a person you just talked with hours earlier.

6-Sep-2022 10:05 AM EDT
New antibody shows therapeutic effects in mice with Alzheimer’s disease
University of Texas Health Science Center at Houston

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.

Newswise: Sanders-Brown researchers receive $20.5 million from National Institute on Aging
Released: 2-Sep-2022 10:05 AM EDT
Sanders-Brown researchers receive $20.5 million from National Institute on Aging
University of Kentucky

A team of researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) has been awarded a $20.5 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH). The P01 award exemplifies team science, helping to support about 35 researchers across six different labs who will be working on four main projects, all with a common theme.

Released: 1-Sep-2022 5:05 PM EDT
Circadian rhythm disruption found to be common among mental health disorders
University of California, Irvine

Irvine, Calif., Sept. 1, 2022 – Anxiety, autism, schizophrenia and Tourette syndrome each have their own distinguishing characteristics, but one factor bridging these and most other mental disorders is circadian rhythm disruption, according to a team of neuroscience, pharmaceutical sciences and computer science researchers at the University of California, Irvine.

Newswise:Video Embedded ochsner-health-expert-available-to-media-during-world-alzheimer-s-month
VIDEO
Released: 31-Aug-2022 6:05 PM EDT
Ochsner Health expert available to media during World Alzheimer’s Month
Ochsner Health

Ochsner Health neuropsychologist John Sawyer, MD, is available to offer comment on Alzheimer’s disease and cognitive and memory disorders.

Released: 29-Aug-2022 5:05 PM EDT
خبير من مايو كلينك يقدم نصائح لتقليل خطر الإصابة بالخَرَف
Mayo Clinic

ُعتقد أن أكثر من 55 مليون شخصٍ حول العالم مصابون بالخَرَف، وفقًا لمنظمة الصحة العالمية. يقول رونالد بيترسون، دكتور الطب، طبيب الأعصاب، ومدير مركز أبحاث داء الزهايمر التابع لمايو كلينك، إنه لا يمكن منع الخَرَف، ولكن يمكن تقليل خطر الإصابة به.

Released: 29-Aug-2022 5:05 PM EDT
妙佑医疗国际(Mayo Clinic)专家谈如何降低痴呆症患病风险
Mayo Clinic

根据世界卫生组织的数据,全球有超过5500万人患有不同程度的痴呆症。Ronald Petersen(医学博士)认为,痴呆症虽然无法预防,但有办法降低患病风险。Petersen博士是一名神经科医生,兼任妙佑医疗国际阿尔茨海默氏症研究中心主任。

Released: 29-Aug-2022 5:05 PM EDT
Especialista da Mayo Clinic dá dicas para reduzir o risco de demência
Mayo Clinic

Acredita-se que mais de 55 milhões de pessoas em todo o mundo vivam com demência, de acordo com a Organização Mundial da Saúde. O Dr. Ronald Petersen, neurologista e diretor do Centro de Pesquisa da Doença de Alzheimer da Mayo Clinic, diz que não é possível evitar a demência, mas que é possível reduzir o risco.

Released: 29-Aug-2022 3:30 PM EDT
Can we reverse the effects of age related memory loss? Experts say yes
Boston University

According to the Alzheimer’s Association, an estimated 6.5 million Americans aged 65 and older are living with Alzheimer’s in 2022. That figure is predicted to nearly double by 2050.

Released: 29-Aug-2022 3:05 PM EDT
Music helps patients with dementia connect with loved ones
Northwestern University

Patients sing and dance with their caregivers to songs from patients’ youth

Newswise: FAU, Israel Scientists ‘Team Up’ to Tackle Alzheimer’s-related Mood Disorders
Released: 29-Aug-2022 8:30 AM EDT
FAU, Israel Scientists ‘Team Up’ to Tackle Alzheimer’s-related Mood Disorders
Florida Atlantic University

Researchers from Florida Atlantic University, in collaboration with Tel Aviv University, have received a two-year, $379,177 grant from the National Institute on Aging, National Institutes for Health, on a collaborative project to study mood-disorders changes in Alzheimer’s disease.

Newswise: Penn State awarded $1.6M to study if COVID-19 contributes to cognitive decline
Released: 25-Aug-2022 9:45 AM EDT
Penn State awarded $1.6M to study if COVID-19 contributes to cognitive decline
Penn State College of Medicine

Penn State College of Medicine received a $1.6 million grant from the National Institutes of Health will support research into whether COVID-19 contributes to the development of cognitive decline.



close
2.7545